Physicians Simulate Real Patient Cases Ushering New Era of Procedure Preparation
BASF’s Dr. Richard Thomas will give a speech on the topic “Anti-infective Surfaces in Medical Devices” at this year’s Compamed congress in November.
A new task force concludes that in certain settings Percutaneous Coronary Intervention can reasonably be considered as a treatment for both left main and three-vessel disease
Boston Scientific Corporation has completed enrollment in a clinical trial to evaluate its WallFlex® Biliary RX Fully Covered Stent for the treatment of benign bile duct strictures.
Aircraft Medical has announced that it has signed an exclusive agreement with Covidien to market and distribute Aircraft’s proprietary McGRATH® MAC video laryngoscope in the United States, United Kingdom, Japan, Latin America, Australia and New Zealand
The Cochrane Collaboration urges free access to all data from all clinical trials: end to selective reporting can reduce the risk of harm to patients
Registration for the annual meeting of the American Association of Orthopaedic Surgeons (AAOS), due to take place in San Francisco Feb 7-11 is now open for members and non members.
Eurospine 2011 takes place this week at the Milano Convention Centre from October 19th to 21st
This week sees the European Association of Neurosurgeons holding its 14th annual congress in Rome.
In a study published in the October 4 issue of Annals of Internal Medicine, cardiologists at Johns Hopkins report that a protocol they developed has proved effective in enabling patients with implanted cardiac devices to safely undergo an MRI scan.
First Ever Randomized, Controlled Clinical Trial in Persistent Atrial Fibrillation (AF) Patients
bbott’s EXCEL is the Largest Trial to Date Designed to Evaluate Optimal Treatment Strategy (Surgery or Stenting) in Patients with Unprotected Left Main Disease
Boston Scientific commences study designed to assess preliminary safety and efficacy of chronic vagal nerve stimulation in heart failure patients
Flexible Stenting Solutions Inc. has announced the successful treatment of the first two patients enrolled in the OPEN (Evaluation of Safety and Efficacy of the FlexStent(R) FemorOPopliteal Self-Expanding StENt System) clinical trial.
Performance for the controversial metal-on-metal (MoM) hip replacement devices continues to create cause for concern, particularly in women, according to this year’s National Joint Registry (NJR) Annual Report.
2011 REPORT OF NATIONAL JOINT REGISTRY OF ENGLAND AND WALES CONFIRMS SUCCESS OF DEPUY JOINT REPLACEMENT PRODUCTS